Clinical Outcomes of MLC601 (NeuroAiD(TM)) in Traumatic Brain Injury: A Pilot Study

Background: MLC601 is a natural product formulation from Chinese medicine that is extensively studied in ischemic stroke. Traumatic brain injury (TBI) shares pathophysiological mechanisms with ischemic stroke, yet there are few studies on the use of MLC601 in treating TBI. This Indonesian pilot stud...

Descripción completa

Detalles Bibliográficos
Autores principales: Al Fauzi, Asra, Prihastomo, Krisna Tsaniadi, Ranuh, I. G. M. Aswin R., Apriawan, Tedy, Wahyuhadi, Joni, Parenrengi, M. Arifin, Turchan, Agus, Bajamal, Abdul Hafid, Notobroto, Hari Basuki
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7071378/
https://www.ncbi.nlm.nih.gov/pubmed/31973204
http://dx.doi.org/10.3390/brainsci10020060

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7071378/
https://www.ncbi.nlm.nih.gov/pubmed/31973204
http://dx.doi.org/10.3390/brainsci10020060

Ejemplares similares